Cellavita-HD

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
8	ハンチントン病	1

8. ハンチントン病

臨床試験数 : 242 / 薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04219241 (ClinicalTrials.gov)	February 10, 2020	11/12/2019	Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HDAdministration in Hunting ...	Clinical Extension Study for Assessing the Safety and Efficacy of the Intravenous Administration of ...	Huntington Disease	Biological: Cellavita-HD	Azidus Brasil	Cellavita Pesquisa Científica Ltda	Active, not recruiting	21 Years	65 Years	All	35	Phase 2/Phase 3	Brazil

First Previous1Next Last